Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
05 sept. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
03 sept. 2024 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Lifecore Biomedical Announces Chief Financial Officer Transition
29 août 2024 07h00 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Contract Development & Manufacturing Organization Market Report 2024: Asia Pacific is the Fastest Growing Market for CDMOs
28 août 2024 04h16 HE
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Contract Development & Manufacturing Organization (CDMO) Market: Insights & Forecast (2024-2028)" report has been added to ...
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
26 août 2024 17h23 HE
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $128.3 million for Fiscal 2024; Year-Over-Year Increase of 24.2% ---- High Value Pipeline Continues to Advance Toward Commercialization ---- State-of-the-Art Technology...
Fill-finish Pharmaceutical Contract Manufacturing Market Research 2024 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F
01 août 2024 11h07 HE
|
Research and Markets
Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "Fill-finish Pharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been...
Global Pharmaceutical Contract Manufacturing Business Research Report 2024: Market to Reach $159.8 Billion by 2030 - Exploring & Exploiting New Technologies for Rich Dividends
31 juil. 2024 04h17 HE
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
India Pharmaceutical Manufacturing Industry Research 2024: Market Size, Share & Trends Analysis 2023-2030
19 juil. 2024 05h39 HE
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "India Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report by Dosage Form (Tablets, Injectables), Manufacturing Type (In-house,...
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
02 juil. 2024 16h05 HE
|
Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and...
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
01 juil. 2024 07h00 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...